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The mouse and other mammals have a 
large number of histocompatibility (H) gene 
loci (perhaps several hundred) controlling 
cell-membrane alloantigens. Only one locus, 
however, is a strong H locus and is termed 
the major histocompatibility complex 
(MHC). A difference between donor and 
recipient at the MHC will prevent the growth 
of nearly all tumor allotransplants and result 
in rapid rejection of skin allografts. The 
murine MHC, (H-2), is located in the ZXth 
linkage group of the 17th chromosome and is 
composed of five regions denoted as K, I, S, 
G, D [l]. The H-2 gene complex has served 
as a model for MHC of other mammals and 
the similarity of H-2 and the HL-A gene 
complex of man is striking. 
In addition to the classical H-2 histocom- 
patibility antigens of the K and D regions, the 
Z region, originally defined by immune 
response (Zr-I) genes [2], contains genes cod- 
ing for a system of lymphocyte alloantigens. 
These antigens have been designated Ia (I 
region associated) [3] and to date 21 spec- 
ificities have been identified (for review, Ref. 
[4]). The Ia antigens have a restricted dis- 
tribution with expression on the majority of B 
lymphocytes and a subpopulation of T 
lymphocytes [5-l I]. 
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The purpose of this study was to determine 
if specific mitogen reactive cells expressed 
the Ia surface molecules and if there was any 
association between the Ia determinant and 
specific mitogen receptors. 
MATERIALS AND METHODS 
Mice. BlO.BR (H-2k) mice were pur- 
chased from Jackson Laboratory, Bar 
Harbor, Maine. All other strains used in ex- 
periments or for antisera production were 
maintained in Dr. Niederhuber’s or Dr. 
Shreffler’s colony at The University of 
Michigan. In each experiment, mice were 
matched for age and sex. 
Antisera. Antisera specific for Ia antigens 
were prepared by reciprocal immunizations 
of A.TH (H-29 and A.TL (H-2 I’) mice with 
lymphoid tissues. A.TH anti-A.TL (Ia”) 
serum and A.TL anti-A.TH (Ias) serum have 
been extensively characterized by micro- 
cytotoxic and absorption studies [4, lo]. 
These sera are consistently cytotoxic for 
70% of lymph node cells and 50% of spleen 
cells. Previous studies have demonstrated 
that the majority of B lymphocytes are Ia 
positive while only a subpopulation of T cells 
carry the Ia determinants [lo]. The IgG frac- 
tion of A.TH anti-A.TL serum was prepared 
by Pevicon block electrophoresis, eluted with 
0.1 M phosphate buffer, and dialyzed against 
tissue culture media [ 121. 
Anti-Thy-l .2 serum was prepared in 
A.AKR (H-2”! Thy-l”) mice against A.AL 
(H-2”, Thy-Z*) thymocytes. Anti-H-2 serum 
specific for the H-2K” determinant (H-2.19) 
was prepared in (A x A.AL),, (H-2”/H-2”‘) 
mice against A.TL (H-2”) cells and anti- 
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serum specific for H-2Kk antigens (H-2.1 1 
and H-2.23) was prepared in A.TL (H-2 ) 
mice by immunizing with A.AL (H-2“‘) cells. 
All normal sera and antisera are clarified by 
centrifugation, heat inactivated, and 
sterilized by passage through a 0.22 pm 
Millipore filter (Millipore Corp., Bedford, 
Mass.). Sera are stored at -70°C in un- 
diluted aliquots. 
Culture conditions. Spleen cells were dis- 
persed by teasing in serum-free RPM1 
1640 media (Microbiological Associates, 
Bethesda, Md.) supplemented with 3 ml of 
Hepes (1 M) and 50 pg/ml gentamycin/ 100 
ml media. Quadruplicate cultures of 5 x lo5 
viable cells were incubated in multi-well 
Linbro plates (Linbro Chemical Co., New 
Haven, Conn.). Cultures were stimulated 
with a dose range of T-cell and B-cell specific 
mitogens. The B-cell mitogen LPS was 
derived from Serratia marcesens (Difco 
Laboratories, Detroit, Mich.) and further 
purified according to the method of Nowotny 
et al. [ 131. Con-A was purchased from 
Calbiochem (Elk Grove Village, Ill.), PHA- 
M was obtained from Difco Laboratories, 
and Leucoagglutinin, a highly purified form 
of PHA was from the Pharmacia Fine 
Chemicals, Uppsala, Sweden. 
Culture plates of lymphoid cells stimulated 
with LPS were incubated for 48 hr at 37°C in 
an atmosphere of 5% COZ. Con-A and PHA 
stimulated cultures were incubated for 72 hr. 
During the last 12-18 hr of culture, 0.2 &i of 
3H-thymidine (2 Ci/mM) was present in the 
cultures. Cultures were harvested with a 
multiple sample harvester (Otto Hiller Co., 
Madison, Wis.), collected on glass fiber 
filters and counted in a liquid scintillation 
counter. 
Thymus-dependent lymphocytes were 
isolated from whole spleen using the 
nylon-wool (LP-1 leuko-pak leukocyte 
filter, Fenwal Laboratories, Morton Grove, 
Ill.) method described by Julius et al. [14]. 
These cells were 80-90% sensitive to anti- 
Thy-l serum plus complement and had no 
significant response to LPS. 
B cells were prepared from whole spleen 
by twice treating the mixed cell population 
with anti-Thy-l.2 serum and complement. 
The resistant cell population was 95% B cells 
and demonstrated no T-cell functions. 
Antiserum treatment of cultured cells. 
For blocking experiments, spleen cells or 
purified T- and B-cell subpopulations were 
incubated for 30 min at 37°C with anti-Ia 
serum, control serum, or normal serum 
without complement. These cells were then 
washed extensively by multiple centrifuga- 
tions in media before culturing. In experi- 
ments where cells bearing the Ia de- 
terminants were actually eliminated from the 
cultured cell population, the cells were first 
incubated with antisera in a dilution of 1:5 or 
1: 10 at 37°C for 20-30 min. The cells were 
then pelleted by slow centrifugation, the anti- 
serum was decanted, and the cells were 
resuspended in agarose absorbed rabbit com- 
plement, incubated for 30 min at 37”C, and 
then washed by centrifugation in media. 
Lysed and damaged cells were removed by 
centrifugation on a gradient of Lymphoprep 
(density 1.077 g/ml) (Nyegaard and Co. 
A/S, Oslo, Norway). The cells were then 
counted in a hemacytometer and adjusted to 
5 x lo6 viable cells/ml. Each culture has 5 
x lo5 cells and the final volume in each cul- 
ture well was 0.3 ml. 
RESULTS 
Anti-la serum blocking of LPS stimula- 
tion. Spleen cells were incubated with appro- 
priate anti-Ia serum without complement for 
30 min at 37°C. The cells were then washed 
by centrifugation in media 3-4 times, Equal 
numbers of viable cells exposed to normal 
serum, anti-H-2 serum, or anti-Ia serum 
were cultured with a dose curve of 0.1 to 100 
pg’glml LPS. The results of five experiments 
show a persistent partial inhibition (35.6% f 
11.8) (P < 0.005) of the response to 50 pg/ml 
of LPS (Table 1). The peak response in con- 
trol cultures occurred with LPS concentra- 
tion of 50 pg/ml. No significant inhibition 
was observed with nonappropriate anti-Ia’ 
serum (3.4% + 13.7) or with anti-H-2K”. 
serum in Expts 2 and 3. In Expt 3 (Table l), 
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TABLE 1 
Inhibition of the LPS Mitogenic Response by Incubating 
Lymphocytes with Anti-Ia Serum before Culturing with LPS 
Expt Strain 
I Antiserum 
region blocking cpm + SD’ 
5% 
Suppression 
1 A.TL k None 
Anti-IaS 
Anti-Iak 




3 A.TL k 
4 BlO.BR k 











Mean suppression 35.6 zt 11.8 
Control 0.4 ct 16.1 
P <0.005 
10461 zt 19446 
11830 f- 3752 
8088 + 914 
10704 +z 2198 
8110 zt 1922 
9741 zt 3876 
5114 f 1190 
4870 f 900 
4959 f 1964 
4374 + 1764 
2837 zt 708 
21569 i 792 
19852 zt 1314 
15902 + 854 
12239 zt 597 
14059 zt 1043 
















“Expressed as counts per minute aH-thymidine incorporation for quadruplicate cultures. 
*Cultures were stimulated with 50 pg/ml LPS. 
‘A.TL-B = splenic B cells prepared by anti-Thy-l.2 serum and complement treatment of whole spleen. 
the spleen cells were incubated with antisera 
for 3 hr, then washed, and cultured with LPS 
without any greater degree of suppression. 
Incubation with more concentrated serum di- 
lutions of 1:2 also failed to increase sup- 
pression, and if incubations with sera were 
prolonged beyond 3 hr, nonspecific sup- 
pression occurred. 
To eliminate the possibility that the 
persistent decrease in responsiveness was the 
effect of anti-Ia serum on T cells, the whole 
spleen cell suspension was treated with anti- 
Thy-l.2 serum and rabbit complement. The 
anti-Thy-l.2 resistent splenic B cells were 
then incubated with A.TH anti-A.TL (Iak) 
serum for 30 min, washed, and cultured with 
LPS (Expt 5, Table 1). The same partial sup- 
pression was observed. Therefore, a Thy-l 
positive, Ia positive auxillary T cell was not 
involved in the suppression. 
The inhibitory effect observed with anti-Ia 
serum was not found when cells were pre- 
treated with antisera specific for H-2K trans- 
plantation antigens, nor with anti-Ia serum 
pretreatment of an irrelevant target cell. 
This indicates that there is no association 
between the H-2K determinants on the cell 
membrane and the receptors(s) for LPS. It 
also demonstrates that simply attaching an 
antibody to the cell surface will not interfere 
with the mitogen proliferative response. 
Nonspecific inhibition of in vitro responses 
by even low concentrations of whole mouse 
serum in the culture media makes it virtually 
impossible to have the desired antibodies 
present throughout the culture period. In 
order to eliminate this problem, the IgG frac- 
tion of A.TH anti-A.TL (a Iak) serum was 
isolated by agarose block electrophoresis. 
This diluted antiserum retained a cytotoxic 
titer of 1:256 and could be present 
throughout the culture period without caus- 
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TABLE 2 
Inhibition of the LPS Mitogenic Response when the IgG Fraction 
of A.TH Anti-A.TL Serum Was Added to Cultures 
Expt Strain 
I cpm + SD’ % 













9438 zt 2650c 
9552 f 1578 
8209 f 506 
5093 + 1536 
3316 + 664 
4236 ct 1416 
2246 zt 538 
2817 + 348 
1742 + 611 
3795 f 337 
2626 f 889 




6973 + 1862 
8529 zt 780 
6181 zt 750 
5414 zt 670 
1944 zt 346 
4443 + 675 
1738 + 208 
3272 f 340 
995 f 345 
2842 +z 294 
1393 zt 358 













35.2 zt 12.2 
3.2 zt 14.9 
‘Expressed as counts per minute sH-thymidine incorporation for quadruplicate cultures. There was no mitogen 
effect of anti-I$(IgG) when it was added to spleen cell cultures. 
b Pool of inhibitory y-fractions from agarose block electrophoesis. 
c Cultures were stimulated with 50 pg/ml LPS. Responses were 2.7-5.0 x control with no LPS. 
ing nonspecific suppression or mitogenic were performed using the T-cell mitogen leu- 
response. The results of six experiments are coagglutinin again without any effect on the 
summarized in Table 2. The mean sup- response. These experiments were always 
pression was 35.2% f 12.2 (P < 0.005) which performed over the complete dose range of 
was no greater than the suppression observed each mitogen to rule out a change in response 
when cells were incubated briefly with anti-Ia kinetics in anti-Ia serum blocked cells. 
antibodies before culturing with LPS. This LPS response of splenic B cells resistant to 
consistent partial suppression of the LPS anti-la serum and complement. BlO.BR (H- 
response suggests an association between the 2’) spleen cells were incubated with normal 
LPS receptor and the Ia molecule(s). A.TH serum or A.TH anti-A.TL serum 
Anti-la serum blocking of Con-A and (anti-Iak) diluted 1:2 followed by an incuba- 
PHA stimulation. In order to test for a tion with rabbit complement. The cells were 
similar inhibition of T-cell mitogen stimula- centrifuged through a Ficoll-Hypaque 
tion, spleen cells were incubated for 30 min gradient, adjusted to equal numbers of viable 
with normal serum, anti-H-2K serum or anti- cells, and cultured with a dose range of LPS. 
Ia serum without complement, washed by The spleen cells resistant to anti-Ia anti- 
centrifugation, and cultured for 72 hr with bodies and complement did not respond to 
mitogen. The anti-Ia serum was A.TH anti- LPS. 
A.TL (a Ia’) serum which is known to have To eliminate the possible involvement of T 
anti-T-cell cytotoxic activity. In four experi- cells, spleen cells were first treated with anti- 
ments, there was no difference in the Con-A Thy-l.2 serum and rabbit complement. After 
or PHA response of serum pretreated cells washing the cells by centrifugation in media, 
when compared to cells exposed only to cul- the anti-Thy-l.2 serum and complement in- 
ture media. Three additional experiments cubation was repeated. The cells resistant to 
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anti-Thy-l.2 serum are greater than 95% B 
cells as determined by surface markers and 
functional assays. The splenic B cells were 
then treated with normal serum and rabbit 
complement or A.TH anti-A.TL (Ia”) serum 
and complement. The remaining viable cells 
after anti-Iak serum treatment constituted 
approximately 8% of the original spleen cell 
population and equal numbers of these cells 
were cultured with 50 pg/ml LPS. The B 
cells resistant to complement dependent 
anti-Ia serum lysis did not respond to LPS 
(Fig. l), indicating that the LPS reactive 
spleen cells are Ia positive B cells. 
BIO.BR k kkk kk 
LPS 50 ugm/ml 
Spleen Cells 
- - 
non I \TI 
B-cells 
FIG. 1. Proliferative response of BlO.BR (H-29 
spleen cells and splenic B cells to 50 pg/ml LPS. Spleen 
cells or anti-Thy-l.2 serum and complement resistant B 
cells were treated either with A.TH normal serum and 
rabbit complement or with A.TH anti-A.TL (aIak) se- 
rum and complement. Equal numbers of surviving via- 
ble cells (5 x 105) were cultured for 48 hr with LPS. 
Each bar represents the mean of four cultures l SE. 
The diferential expression of the Ia 
marker on PHA and Con-A reactive T cells. 
Spleen cells from BIO.S (H-2”) mice were 
subjected to lysis by A.TL anti-A.TH (anti- 
Ias) serum and rabbit complement, killing 
50-60s of the lymphocytes. Equal numbers 
of viable Ia” negative cells were cultured with 
Con-A or leucoagglutinin. These cells 
FIG. 2. Con-A and leucoagglutinin proliferative 
response of A.TL anti A.TH (aIas) serum and rabbit 
complement treated Bl0.S (H-2’) spleen cells. NT is the 
response obtained when cells were exposed only to cul- 
ture media. A.TL-ns + C’ represents the response of 
cells treated with normal serum and rabbit complement. 
Equal numbers of remaining viable cells (5 x 105) were 
cultured for 72 hr with either Con-A, 1 fig/ml (open 
bars) or leucoagglutinin, 1 fig/ml (shaded bars). Each 
bar represents the mean response of four cultures 
expressed as cpm =t SD, The open bar at the left of the 
graph is the background response in unstimulated cul- 
tures. 
responded normally to leucoagglutinin but 
did not respond to Con-A (Fig. 2). Four ex- 
periments were performed including two with 
BlO.BR (H-27 spleen cells and A.TH anti- 
A.TL (Iak) serum with identical results. 
The experiments were repeated using 
splenic T cells isolated by incubating the 
spleen cell mixture on nylon-wool columns. 
The first cells washed off the column by the 
addition of 15 ml culture media were greater 
than 90% Thy-l.2 positive T cells. The 
nylon-wool T cells were incubated with anti- 
Ia serum and complement. Equal numbers of 
surviving T cells were cultured with Con-A, 
PHA, or leucoagglutinin. These cells failed 
to respond to Con-A (Fig. 3). Although not 
shown in Fig. 3, these cells gave a normal 
response to PHA and leucoagglutinin. 
The Con-A sensitive lymphocyte, there- 
fore, is a Thy-l positive, Ia positive T 
cell distinct from the PHA or leucoagglutinin 




recent findings. For example, Cantor and 
Boyse [18, 191 and Kisielow et al. [20] have 
14. 
/ I demonstrated that “helper” T cells are dis- 
tinct from “killer” T cells and that “helper” 
cells express the Ly-1 antigen while “killer” 
cells express Ly-2,3. Graft-vs-host cells com- 
prise yet another subpopulation and express 
Ly-1 and Ly-2 antigens. 
Cytotoxic and absorption studies have indi- 
cated that the la antigens are expressed on 
the membranes of most B lymphoid cells and 
macrophages. It was, therefore, not surpris- 
ing that the removal of the majority of the 
splenic B cells by anti-Ia serum and comple- 
ment eliminated the response to LPS. More 
significant were the experiments designed to 
test if the simple binding of specific anti-Ia 
FIG. 3. Con-A proliferative response of nylon-wool 
antibodies to the cell membrane would inter- 
purified splenic T-cells resistant to treatment with A.TH fere with mitogen stimulation. These experi- 
anti A.TL (aIak) serum and rabbit complement. Equal ments were important for two reasons. First, 
numbers of surviving viable cells (5 x 10s) were cultured it was recently shown that LPS is a potent 
for 72 hr with mitogen. (o-) Nontreated splenic T cells 
from Bl0.K (H-p) mice; (o-) anti-Iak serum plus com- 
polyclonal B cell activator nonspecifically in- 
plement treated BIOS (H-29 cells; and (o-) anti-Iak 
ducing immunocompetent B cells to pro- 
serum plus complement treated Bl0.K cells. Each point liferate and/or secrete antibody [21, 221. 
represents the mean response of four cultures expressed This cell triggering occurs without the in- 
as counts per minute + SD. volvement of the variable part of the Ig 
DISCUSSION 
receptor and is not dependent upon acces- 
sory cells (for review, Ref. [23]). Second, 
These experiments have defined a sub- we observed that covering of the Ia surface 
population of Con-A reactive T lymphocytes molecule(s) of spleen cells with specific anti- 
which is Ia and Thy-l positive and distinct Ia antibodies inhibited the in vitro primary 
from the subset of T cells which is PHA or and secondary humoral response to heterolo- 
leucoagglutinin reactive. The latter subpopu- gous erythrocytes [24]. This blocking of the 
lation is Thy-l positive but is not susceptible humoral response was specific for anti-Ia 
to lysis by anti-Ia serum and complement. serum with no inhibition occurring with anti- 
The demonstration of a functional class of Ia H-2K serum. These experiments implicate 
reactive T cells supports the findings of our the involvement of the Ia determinant in cell 
previous cytotoxic and absorption studies in- triggering and/or cell collaboration in the im- 
dicating the existence of an Ia positive T cell mune response. The finding, therefore, that 
population [lo]. Demonstration of Ia positive simple pretreatment of splenic B cells with 
thymocytes by other investigators using the anti-Ia serum without complement also sup- 
fluorescence-activated cell sorter [ 181 and of pressed the LPS proliferative response sug- 
Ia sensitive Con-A activated thymocyte and gests the involvement of the Ia molecule in 
splenic blasts [ 16, 171 give additional support the events of B cell triggering. The fact that 
to these observations. this suppression was only partial (- 30%) 
The fact that distinct subsets of T necessitated the performance of a number of 
lymphocytes are specific for Con-A and PHA experiments to insure that this was a 
mitogens and that they also have differing Ia consistent observation. 
expression is consistent with a number of It is unlikely that the observed blocking 
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was mediated by the Fc portion of the anti-la 
antibody molecule since antibodies specific 
for H-2K and H-2D determinants had no de- 
tectable effect. For the observed blocking 
with anti-Ia whole serum or with the IgG 
fraction of anti-Ia serum to occur via the Fc 
portion of the antibody, one must assume 
that the anti-la heavy chains have a unique 
constant region. This would be highly un- 
likely. 
The inhibition was clearly a B cell specific 
event since it was not affected by elimination 
of splenic T cells. The most obvious in- 
terpretation is that the Ia molecule(s) and 
LPS receptors(s) are either the same mole- 
cule, or they are in the same supramo- 
lecular complex on the cell membrane. The 
fact that inhibition was only partial suggests, 
rather, that if LPS triggering is a simple 
switch event, then some cells have la and 
LPS receptors in close association on their 
membranes and are inhibited while other 
cells have non-Ia associated LPS receptors 
and are triggered. This could also imply the 
existence of at least two classes of LPS 
receptor molecules. 
Andersson et al. [25] have observed that 
antibodies directed against the Ig receptors 
on B cells had no effect on the LPS prolifera- 
tive response but did inhibit the LPS induc- 
tion of polyclonal IgM synthesis. Further- 
more, “capping” of surface Ig on B cells did 
not interfere with their proliferative response 
to LPS [26]. Therefore, it also will be im- 
portant to test the ability of anti-la serum to 
inhibit polyclonal responses to LPS and other 
B cell mitogens. 
The failure to block Con-A stimulation by 
the pretreatment of spleen cells with anti-Ia 
serum may simply reflect the fact that the 
receptors for this mitogen are quite distinct 
from surface Ia determinants. The absence 
of mannose, the membrane binding sugar for 
Con-A, in the Ia antigen structure also may 
be significant. 
There is no question that the Ia molecules 
are distinct from classical transplantation 
antigens. They are found on molecules with a 
molecular weight of 25,000 to 33,000 daltons 
[ 111, are glycoproteins [27], and cap inde- 
pendently of the H-2K and H-2D trans- 
plantation antigens [28]. Recently it has been 
shown that anti-Ia sera react directly with 
both cell-bound and soluble molecules in- 
volved in a number of immune phenomena 
[29]. This surface marker and the antisera 
directed against the multiple specificities of 
this region, therefore, will be important tools 
in the further study of the events of antigen 
recognition, cell triggering, and cellular 
interaction in the immune response. 
SUMMARY 
Genes located in the I region of the H-2 
complex control a system of lymphocyte allo- 
antigens (Ia) which are expressed on sub- 
populations of T and B cells. Specific anti-Ia 
serum plus rabbit complement removed the 
B-lymphocyte population responsive to the 
mitogen LPS and the subpopulation of T 
cells responsive to Con-A. Lymphocytes 
sensitive to PHA or leucoagglutinin were not 
removed by anti-Ia serum and complement. 
Significant inhibition of the proliferative 
response to LPS was also obtained by brief 
periods of cell pretreatment with anti-Ia anti- 
bodies without complement. This inhibition 
was specific with the appropriate anti-Ia 
serum and did not occur with anti-H-2K sera 
or when cells of a different I region were pre- 
treated. 
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